Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ron Beaney"'
Publikováno v:
Journal of Neuro-Oncology. 67:351-359
Investigations of the effects of radiation on neuropsychological functions have revealed variable outcomes, ranging from no effect to severe cognitive impairment. However, many of the previous studies have relied on retrospective data or have been li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6107d73120a45edfa7a885d89803dd57
https://doi.org/10.1023/b:neon.0000024239.99645.42
https://doi.org/10.1023/b:neon.0000024239.99645.42
Autor:
Alex King, Ron Beaney, Katia Cikurel, Lucy Brazil, Craig Knighton, Jamie Logan, Vicky Hurwitz, Andrew Hodgkiss
INTRODUCTION: We recorded over a 9 month period the number of referrals made for specialist advice on how to treat a patient's psychiatric condition from those attending our neuro-oncology clinics. The patient's characteristics were reviewed to under
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6612b5533dcdf777ddcbec9c6e50dc18
https://europepmc.org/articles/PMC4200968/
https://europepmc.org/articles/PMC4200968/
Autor:
Keyoumars Ashkan, Lawrence Doey, Ross Laxton, Andy King, Safa Al-Sarraj, Lucy Brazil, Ranj Bhangoo, Ron Beaney, Miren Aizpurua, Istvan Bodi, Chris Chandler
Publikováno v:
Journal of Molecular and Genetic Medicine.
Background: MGMT methylation, along with 1p/19q co-deletion and IDH1 mutation, is an important biomarker in high grade gliomas. MGMT methylation indicates an improved response to temozolomide chemotherapy; patients with 1p/19q co-deleted anaplastic o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e119ef7cf73d9ca3bd6c5f12710f9af
https://doi.org/10.4172/1747-0862.1000151
https://doi.org/10.4172/1747-0862.1000151
Autor:
Safa Al-Sarraj, Istvan Bodi, Ross Laxton, K. Ashkan, Ron Beaney, Miren Aizpurua, Lucy Brazil, Lawrence Doey, Andy King, Ranjeev Bhangoo
Publikováno v:
Neuro-Oncology. 17:viii2.6-viii3
INTRODUCTION: Previously we have shown that glioblastomas with an oligodendroglial component (GBMO) did not differ from other glioblastomas in the frequency of 1p/19q deletion or isocitrate dehydrogenase mutation. Here we seek to determine whether an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31b75c50d281e5dcc750f662069d1daa
https://doi.org/10.1093/neuonc/nov284.11
https://doi.org/10.1093/neuonc/nov284.11
Publikováno v:
Journal of Neuro-Oncology; May2004, Vol. 67 Issue 3, p351-359, 9p